Medical treatment of eosinophilic esophagitis-Reference-Cited by-同舟云学术

Medical treatment of eosinophilic esophagitis

Published:2023-07-20 Issue:7 Volume:2023 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Franciosi James P¹²,Gordon Morris³,Sinopoulou Vassiliki³,Dellon Evan S⁴,Gupta Sandeep K⁵,Reed Craig C⁴,Gutiérrez-Junquera Carolina⁶,Venkatesh Rajitha D⁷,Erwin Elizabeth A⁸,Egiz Abdullah³,Elleithy Assem³,Mougey Edward B⁹

Affiliation:

1. Division of Gastroenterology, Hepatology, and Nutrition; Nemours Children's Hospital; Orlando FL USA

2. College of Medicine; University of Central Florida; Orlando USA

3. School of Medicine; University of Central Lancashire; Preston UK

4. Department of Medicine, Division of Gastroenterology and Hepatology, Center for Esophageal Diseases and Swallowing; University of North Carolina School of Medicine; Chapel Hill NC USA

5. Division of Pediatric Gastroenterology, Hepatology and Nutrition; University of Illinois College of Medicine at Peoria and Children's Hospital of Illinois; Peoria IN USA

6. Pediatric Gastroenterology; University Hospital Puerta de Hierro Majadahonda. Autonomous University of Madrid; Madrid Spain

7. Pediatrics, Gastroenterology & Hepatology & Nutrition; Nationwide Children's Hospital; Columbus OH USA

8. Pediatric Allergy; Nationwide Children's Hospital; Columbus OH USA

9. Clinical Pharmacogenomics and Translational Research; Nemours Children's Health System; Jacksonville FL USA

Publisher

Wiley

Subject

Pharmacology (medical)

Reference354 articles.

1. A randomized placebo-controlled trial of swallowed fluticasone as treatment of eosinophilic esophagitis 2010 ACG auxiliary award;Alexander;American Journal of Gastroenterology,2010

2. Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis;Alexander;Clinical Gastroenterology and Hepatology,2012

3. Topical steroid treatment for eosinophilic esophagitis https://clinicaltrials.gov/ct2/show/NCT00275561

4. A randomized placebo-controlled trial of montelukast in maintenance treatment of eosinophilic esophagitis;Alexander;Gastroenterology,2016

5. Montelukast does not maintain symptom remission after topical steroid therapy for eosinophilic esophagitis;Alexander;Clinical Gastroenterology and Hepatology,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathomorphological criteria and features of immune response in eosinophilic esophagitis and reflux esophagitis;Arkhiv patologii;2024

2. For people with eosinophilic esophagitis, how do corticosteroids or biologics compare with placebo for induction of remission?;Cochrane Clinical Answers;2023-12-12

3. Updates in Eosinophilic Esophagitis;Current Treatment Options in Pediatrics;2023-12-02

4. Assessment of the Severity and the Remission Criteria in Eosinophilic Esophagitis;Biomedicines;2023-12-01

5. Mechanistic Insights into Eosinophilic Esophagitis: Therapies Targeting Pathophysiological Mechanisms;Cells;2023-10-18